Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis

被引：14
作者：
Castilla, J. [1 ,2 ]
Martinez-Baz, I. [1 ,2 ]
Navascues, A. [3 ]
Fernandez-Alonso, M. [4 ]
Reina, G. [4 ]
Guevara, M. [1 ,2 ]
Chamorro, J. [3 ]
Ortega, M. T. [5 ]
Albeniz, E. [6 ]
Pozo, F. [7 ]
Ezpeleta, C. [3 ]
机构：
[1] Inst Salud Publ Navarra, Pamplona, Spain
[2] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Network Biomed Res Ctr Epidemiol & Publ Hlth, Valencia, Spain
[3] Complejo Hosp Navarra, Pamplona, Spain
[4] Univ Navarra Clin, Pamplona, Spain
[5] Hosp Reina Sofia, Tudela, Spain
[6] Direcc Atenc Primaria, Navarre Hlth Serv, Pamplona, Spain
[7] WHO Natl Influenza Ctr Madrid, Ctr Nacl Microbiol, Inst Salud Carlos III, Majadahonda, Spain
来源：
EUROSURVEILLANCE | 2014年 / 19卷 / 06期
关键词：
D O I：
10.2807/1560-7917.ES2014.19.6.20700
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We estimate mid-2013/14 season vaccine effectiveness (VE) of the influenza trivalent vaccine in Navarre, Spain. Influenza-like illness cases attended in hospital (n=431) and primary healthcare (n=344) were included. The overall adjusted VE in preventing laboratory-confirmed influenza was 24% (95% CI: -14 to 50). The VE was 40% (95% CI: -12 to 68) against influenza A(H1)pdm09 and 13% (95% CI: -36 to 45) against influenza A(H3). These results suggest a moderate preventive effect against influenza A(H1)pdm09 and low protection against influenza A(H3).
引用
收藏
页码：15 / 21
页数：7
相关论文
共 50 条
  • [21] Influenza Vaccine Effectiveness in Preventing Hospitalizations With Laboratory-Confirmed Influenza in Greece During the 2014-2015 Season: A Test-Negative Study
    Lytras, Theodore
    Kossyvakis, Athanasios
    Melidou, Angeliki
    Andreopoulou, Anastasia
    Exindari, Maria
    Gioula, Georgia
    Kalliaropoulos, Antonios
    Tryfinopoulou, Kyriaki
    Pogka, Vasiliki
    Spala, Georgia
    Malisiovas, Nikolaos
    Mentis, Andreas
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (11) : 1896 - 1904
  • [22] Effectiveness of the influenza vaccine for preventing laboratory-confirmed influenza infections in outpatient immunocompromised adults, 2017-2018
    Kramer, Kailey Hughes
    Zimmerman, Richard K.
    Haggerty, Catherine L.
    Balasubramani, G. K.
    Nowalk, Mary Patricia
    Martin, Emily T.
    Gaglani, Manjusha
    Phillips, C. Hallie
    Belongia, Edward
    Chung, Jessie
    Silveira, Fernanda P.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [23] Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016-2017 Season: Insights Into Novel Age-Specific Analysis
    Stein, Yaniv
    Mandelboim, Michal
    Sefty, Hanna
    Pando, Rakefet
    Mendelson, Ella
    Shohat, Tamy
    Glatman-Freedman, Aharona
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (09) : 1383 - 1391
  • [24] Vaccine Effectiveness against Medically Attended Laboratory-Confirmed Influenza in Japan, 2011-2012 Season
    Suzuki, Motoi
    Minh, Le Nhat
    Yoshimine, Hiroyuki
    Inoue, Kenichiro
    Yoshida, Lay Myint
    Morimoto, Konosuke
    Ariyoshi, Koya
    PLOS ONE, 2014, 9 (02):
  • [25] Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season
    Mira-Iglesias, Ainara
    Lopez-Labrador, Fxavier
    Baselga-Moreno, Victor
    Tortajada-Girbes, Miguel
    Mollar-Maseres, Juan
    Carballido-Fernandez, Mario
    Schwarz-Chavarri, German
    Puig-Barbera, Joan
    Diez-Domingo, Javier
    EUROSURVEILLANCE, 2019, 24 (31) : 11 - 22
  • [26] Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
    Pebody, R.
    Warburton, F.
    Ellis, J.
    Andrews, N.
    Potts, A.
    Cottrell, S.
    Johnston, J.
    Reynolds, A.
    Gunson, R.
    Thompson, C.
    Galiano, M.
    Robertson, C.
    Byford, R.
    Gallagher, N.
    Sinnathamby, M.
    Yonova, I.
    Pathirannehelage, S.
    Donati, M.
    Moore, C.
    de Lusignan, S.
    McMenamin, J.
    Zambon, M.
    EUROSURVEILLANCE, 2016, 21 (38) : 41 - 51
  • [27] Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis
    Castilla, J.
    Navascues, A.
    Casado, I.
    Diaz-Gonzalez, J.
    Perez-Garcia, A.
    Fernandino, L.
    Martinez-Baz, I.
    Aguinaga, A.
    Pozo, F.
    Ezpeleta, C.
    EUROSURVEILLANCE, 2017, 22 (07): : 11 - 16
  • [28] Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014
    McNeil, S. A.
    Shinde, V.
    Andrew, M.
    Hatchette, T. F.
    Leblanc, J.
    Ambrose, A.
    Boivin, G.
    Bowie, W. R.
    Diaz-Mitoma, F.
    ElSherif, M.
    Green, K.
    Haguinet, F.
    Halperin, S.
    Ibarguchi, B.
    Katz, K.
    Langley, J. M.
    Lagace-Wiens, P.
    Light, B.
    Loeb, M.
    McElhaney, J.
    MacKinnon-Cameron, D.
    McCarthy, A. E.
    Poirier, M.
    Powis, J.
    Richardson, D.
    Semret, M.
    Smith, S.
    Smyth, D.
    Stiver, G.
    Trottier, S.
    Valiquette, L.
    Webster, D.
    Ye, L.
    McGeer, A.
    EUROSURVEILLANCE, 2014, 19 (09): : 16 - 21
  • [29] Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season
    Wu, Shuangsheng
    Pan, Yang
    Zhang, Xinxin
    Zhang, Li
    Duan, Wei
    Ma, Chunna
    Zhang, Yi
    Zhang, Man
    Sun, Ying
    Yang, Peng
    Wang, Quanyi
    Ma, Jun
    VACCINE, 2018, 36 (38) : 5774 - 5780
  • [30] Vaccine effectiveness against laboratory-confirmed influenza in Europe - Results from the DRIVE network during season 2018/19
    Stuurman, Anke L.
    Bollaerts, Kaatje
    Alexandridou, Maria
    Biccler, Jorne
    Domingo, Javier Diez
    Nohynek, Hanna
    Rizzo, Caterina
    Turunen, Topi
    Riera-Montes, Margarita
    VACCINE, 2020, 38 (41) : 6455 - 6463
12345